相似文献
1
Susceptibility of 186 Nocardia sp. isolates to 20 antimicrobial agents.
Antimicrob Agents Chemother. 2011 Jun;55(6):2995-8. doi: 10.1128/AAC.01279-10. Epub 2011 Mar 14.
2
Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain.
J Antimicrob Chemother. 2017 Mar 1;72(3):754-761. doi: 10.1093/jac/dkw489.
3
Antimicrobial susceptibility among clinical Nocardia species identified by multilocus sequence analysis.
Antimicrob Agents Chemother. 2015 Jan;59(1):269-75. doi: 10.1128/AAC.02770-14. Epub 2014 Oct 27.
4
Antimicrobial susceptibility profiles and species distribution of medically relevant Nocardia species: Results from a large tertiary laboratory in Australia.
J Glob Antimicrob Resist. 2020 Mar;20:110-117. doi: 10.1016/j.jgar.2019.06.018. Epub 2019 Aug 7.
5
[Antimicrobial susceptibilities of clinical Nocardia isolates identified by 16S rRNA gene sequence analysis].
Mikrobiyol Bul. 2016 Jan;50(1):11-20. doi: 10.5578/mb.10639.
6
Identification and antimicrobial susceptibility of referred isolates in Victoria, Australia 2009-2019.
J Med Microbiol. 2022 Aug;71(8). doi: 10.1099/jmm.0.001581.
7
Susceptibility profiles of Nocardia isolates based on current taxonomy.
Antimicrob Agents Chemother. 2014;58(2):795-800. doi: 10.1128/AAC.01531-13. Epub 2013 Nov 18.
8
MLSA phylogeny and antimicrobial susceptibility of clinical Nocardia isolates: a multicenter retrospective study in China.
BMC Microbiol. 2021 Dec 13;21(1):342. doi: 10.1186/s12866-021-02412-x.
9
Clinical features, identification, antimicrobial resistance patterns of Nocardia species in China: 2009-2017.
Diagn Microbiol Infect Dis. 2019 Jun;94(2):165-172. doi: 10.1016/j.diagmicrobio.2018.12.007. Epub 2018 Dec 29.
10
Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest.
Clin Microbiol Infect. 2006 Sep;12(9):905-12. doi: 10.1111/j.1469-0691.2006.01460.x.
引用本文的文献
1
Successful Treatment of Brain Abscess Caused by with Combination Therapy Despite Discrepancies in In Vitro Results: A Case Report and Review of Diagnostic and Therapeutic Challenges.
Microorganisms. 2025 Jun 30;13(7):1536. doi: 10.3390/microorganisms13071536.
2
A rare case of multiple brain abscesses caused by Nocardia abscessus co-infection with tuberculous meningitis in an immunocompetent patient.
BMC Infect Dis. 2025 May 13;25(1):694. doi: 10.1186/s12879-025-11056-5.
3
Liver cirrhosis complicated with pulmonary Nocardia infection: A case report and literature review.
Medicine (Baltimore). 2024 Dec 6;103(49):e40054. doi: 10.1097/MD.0000000000040054.
4
Nocardia farcinica pneumonia complicated by pneumocystis jiroveci infection in children with Neuromyelitis Optica Spectrum Disorders: a case report and literature review.
Ital J Pediatr. 2024 Dec 2;50(1):255. doi: 10.1186/s13052-024-01827-2.
5
Case report: Metagenomic next-generation sequencing for the diagnosis of rare infection in a patient with immune thrombocytopenia.
Front Med (Lausanne). 2024 Nov 6;11:1425655. doi: 10.3389/fmed.2024.1425655. eCollection 2024.
6
Secreted protein NFA47630 from Nocardia farcinica IFM10152 induces immunoprotective effects in mice.
Trop Dis Travel Med Vaccines. 2024 Oct 15;10(1):21. doi: 10.1186/s40794-024-00229-w.
7
Application of MALDI-TOF mass spectrometry for identification of Nocardia species.
BMC Microbiol. 2024 Sep 20;24(1):358. doi: 10.1186/s12866-024-03483-2.
8
Disseminated Nocardia nova in a child with relapsed acute lymphoblastic leukemia: a case report.
BMC Infect Dis. 2024 Feb 1;24(1):154. doi: 10.1186/s12879-023-08895-5.
9
Rare occurrence of pulmonary coinfection involving Aspergillus fumigatus and Nocardia cyriacigeorgica in immunocompetent patients based on NGS: A case report and literature review.
Medicine (Baltimore). 2023 Dec 22;102(51):e36692. doi: 10.1097/MD.0000000000036692.
10
First Report of Clivus Osteomyelitis Caused by Nocardia veterana in a Lung Transplant Recipient.
Cureus. 2023 Mar 21;15(3):e36487. doi: 10.7759/cureus.36487. eCollection 2023 Mar.
本文引用的文献
1
In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid.
Antimicrob Agents Chemother. 2010 May;54(5):2191-3. doi: 10.1128/AAC.01520-09. Epub 2010 Mar 22.
2
Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species.
J Antimicrob Chemother. 2009 Jul;64(1):73-8. doi: 10.1093/jac/dkp144. Epub 2009 Apr 27.
3
Pulmonary nocardiosis: risk factors, clinical features, diagnosis and prognosis.
Curr Opin Pulm Med. 2008 May;14(3):219-27. doi: 10.1097/MCP.0b013e3282f85dd3.
4
Nocardia wallacei sp. nov. and Nocardia blacklockiae sp. nov., human pathogens and members of the "Nocardia transvalensis Complex".
J Clin Microbiol. 2008 Apr;46(4):1178-84. doi: 10.1128/JCM.02011-07. Epub 2008 Feb 6.
5
Clinical and microbiological features of nocardiosis 1997-2003.
J Med Microbiol. 2007 Apr;56(Pt 4):545-550. doi: 10.1099/jmm.0.46774-0.
6
In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods.
Antimicrob Agents Chemother. 2007 Mar;51(3):1102-4. doi: 10.1128/AAC.01102-06. Epub 2006 Dec 28.
7
Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest.
Clin Microbiol Infect. 2006 Sep;12(9):905-12. doi: 10.1111/j.1469-0691.2006.01460.x.
8
Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.
Clin Microbiol Rev. 2006 Apr;19(2):259-82. doi: 10.1128/CMR.19.2.259-282.2006.
9
Nocardiosis: review of clinical and laboratory experience.
J Clin Microbiol. 2003 Oct;41(10):4497-501. doi: 10.1128/JCM.41.10.4497-4501.2003.
10
Infection caused by Nocardia farcinica: case report and review.
Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):205-12. doi: 10.1007/s100960050460.
Zotero 插件